Phase 1 Study Testing the Combination of Aflibercept and Capecitabine in Metastatic Digestive and Breast Cancers

NCT01843725 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

37

Enrollment

OTHER

Sponsor class

Conditions

Metastatic Colorectal Cancers
Metastatic Gastric Cancers
Metastatic Oesophageal Cancers
Metastatic Pancreatic Cancers
Metastatic Biliary Cancers
Metastatic Breast Cancers

Interventions

DRUG: capecitabine
DRUG: aflibercept
DRUG: Capecitabine

Sponsor

Jules Bordet Institute